Akorn Must Face Claims In VersaPharm Integration Suit
A group of Akorn Inc. shareholders got the go-ahead Monday in Illinois federal court to proceed with their claims that officials of the drugmaker inflated share prices by withholding damaging financial...To view the full article, register now.
Already a subscriber? Click here to view full article